22 April 2016 - A clinical advice meeting was held on 12 February 2016 to discuss the place of eculizumab (Soliris) for the treatment of patients with atypical haemolytic uraemic syndrome in the context of renal transplantation.

For more details, go to: http://www.pbs.gov.au/industry/listing/elements/pbac-meetings/pbac-stakeholder-meetings/eculizumab-soliris-atypical-haemolytic-uraemic-syndrome-february-2016.pdf